Although the measurements are nearly identical, they are located inside the limiting curve regarding reactive power capability, due to a very small safety margin
The 2.5 mg dose is used for initial titration to improve tolerability and is not considered effective for glycemic control
Because of this, it's primarily studied and used for cognitive benefitsfocus, mental clarity, and neurological health
For weight-related treatment goals, especially where Zepbound (the weight-lossspecific brand of tirzepatide) is approved, titration may progress beyond 5 mg depending on how well the patient responds
Ive stopped it a couple times here and there, but after week 2-3 Im reminded why Im taking it when my real appetite starts coming back
Blood 91: 3817-3824.CrossRefGoogle Scholar MURRAY, R.K., GRANNER, D.K., MAYES, P.A